Microplastics and Nanomaterials: Understanding Emerging Contaminants in Environmental Testing

🎤Matthew BolinoHow do the hidden carbohydrate structures on your favorite protein powders shape the gut microbiome? &nbsp;In this episode of Concentrating on Chromatography, Matthew Bolino, M.S., from the University of Nevada, Reno, breaks down his latest research on N‑glycans from common dietary proteins (whey, egg white, soy, and pea) and how their structural diversity influences microbial fermentation and short‑chain fatty acid production.Bolino explains what N‑glycans are, why they behave like fiber in the gut, and how his team isolates and characterizes them using ethanol washes, enzymatic release (PNGase F and gut‑derived endoglycosidases), and advanced MALDI‑TOF and HILIC‑QTOF workflows. &nbsp;He also discusses his 2025 work comparing synthetic versus bovine whey N‑glycomes and mapping N‑glycan profiles across dietary protein sources, revealing how glycan architecture can reshape community diversity in in vitro fecal fermentations.Geared toward undergraduate and early‑career analytical chemists, this conversation dives into practical mass spec trade‑offs (MALDI vs QTOF vs LC/GC), real‑world troubleshooting in glycomics labs, and how microbiome‑targeted therapeutics and “symbiotic” designs may emerge from pairing specific microbes with preferred glycan structures. &nbsp;Bolino closes with career advice on building biomolecular analysis skills, understanding instrumentation fundamentals, and entering the rapidly growing field of glycomics and microbiome research.<h3>Video Transcription</h3><h4>Introduction</h4>Glycomics has emerged as a rapidly developing field within biomolecular science, expanding our understanding of post-translational modifications beyond well-known processes such as phosphorylation. Among these modifications, protein glycosylation—the covalent attachment of carbohydrate structures to proteins—plays a critical role in biological function, molecular recognition, and cellular communication.This discussion focuses on N-glycans, a class of structurally complex carbohydrates linked to proteins, and their occurrence in common dietary protein sources such as whey, egg white, soy, and pea protein. Particular emphasis is placed on their structural diversity, analytical workflows, and emerging relevance in gut microbiome research.<h4>Fundamentals of N-Glycans</h4>N-glycans are oligosaccharide structures covalently attached to proteins via nitrogen atoms, typically at asparagine residues. They represent one of the two major classes of protein glycosylation, alongside O-glycans.These glycans are characterized by:<ul><li>High structural diversity, arising from variations in monosaccharide composition and linkage patterns</li><li>Large size, typically comprising 7–15 monosaccharide units</li><li>Complex branching architectures, leading to a vast number of possible configurations</li></ul>Common monosaccharide components include:<ul><li>Mannose</li><li>Galactose</li><li>N-acetylglucosamine</li><li>N-acetylgalactosamine</li><li>Sialic acids</li></ul>Unlike free carbohydrates present in foods (e.g., glucose, lactose), N-glycans are protein-bound, which significantly influences their biological behavior.<h4>Biological Function and Dietary Relevance</h4>N-glycans play multiple roles in biological systems, including:<ul><li>Modulation of protein stability</li><li>Regulation of protein trafficking and localization</li><li>Facilitation of cell–cell communication and immune recognition</li></ul>They are particularly abundant on membrane and surface proteins, where they contribute to molecular signaling processes.From a dietary perspective, N-glycans exhibit unique behavior. Due to their size and protein-bound nature, they are not readily digested in the upper gastrointestinal tract. Instead, they can reach the colon, where they may function analogously to dietary fiber, interacting with the gut microbiota.<h4>Research Motivation</h4>The investigation of N-glycans in dietary proteins was initially driven by interest in protein nutrition and supplementation, particularly in the context of muscle growth and protein quality. However, this focus expanded upon recognition of the importance of glycosylation in biological systems.The field of glycomics offers:<ul><li>Extensive structural variability, enabling diverse biological functions</li><li>Relevance in disease mechanisms, including cancer, where glycosylation patterns can influence immune evasion</li><li>Opportunities to explore diet–microbiome interactions</li></ul>This combination of nutritional, biochemical, and biomedical relevance makes N-glycan research particularly compelling.<h4>Experimental Workflow for N-Glycan Analysis</h4>The analysis of N-glycans requires a multi-step workflow due to their covalent attachment to proteins.<h5>1. Protein Purification</h5>Dietary protein samples often contain:<ul><li>Free sugars</li><li>Lipids</li><li>Other matrix components</li></ul>To isolate glycoproteins:<ul><li>Cold ethanol precipitation is used to remove free carbohydrates</li><li>Multiple washing steps ensure removal of residual sugars</li><li>A phenol–sulfuric acid assay is applied to confirm the absence of free sugars</li></ul><h5>2. Enzymatic Release of N-Glycans</h5>N-glycans are enzymatically cleaved from proteins using:<ul><li>PNGase F (Peptide-N-Glycosidase F)</li></ul>This enzyme:<ul><li>Specifically cleaves the glycan from the protein backbone</li><li>Preserves the intact glycan structure</li></ul>Alternative approaches using gut-derived enzymes are being explored to improve accessibility and yield.<h5>3. Glycan Purification and Labeling</h5>Following release:<ul><li>Glycans are purified from the protein matrix</li><li>Chemical labeling is performed (e.g., 2-AA or procainamide tagging)</li></ul>Labeling enhances:<ul><li>Detection sensitivity</li><li>Chromatographic behavior</li></ul><h5>4. Analytical Techniques</h5>Two primary analytical platforms are employed:<ul><li>MALDI-TOF MS<ul><li>High sensitivity</li><li>Broad structural coverage</li></ul></li><li>HILIC-LC-MS<ul><li>Improved reproducibility</li><li>Enhanced chromatographic separation</li></ul></li></ul>These approaches provide semi-quantitative data, where signal intensity reflects relative abundance rather than absolute concentration.<h4>Analytical Challenges</h4>Several challenges are associated with N-glycan analysis:<h5>Low Abundance</h5><ul><li>Dietary proteins typically contain only 1–2% glycan content by weight</li><li>This limits yield and complicates downstream applications</li></ul><h5>Sample Preparation Complexity</h5><ul><li>Extensive purification is required to eliminate free sugars</li><li>Contamination risks must be carefully managed</li></ul><h5>Instrumentation Trade-Offs</h5><ul><li>Different analytical platforms offer complementary advantages</li><li>No single technique provides complete structural and quantitative information</li></ul><h4>Differences Between Plant and Animal N-Glycans</h4>Comparative analysis reveals distinct differences in glycan composition:<h5>Plant-Derived Proteins (e.g., soy, pea)</h5><ul><li>Predominantly high-mannose structures</li><li>Lower monosaccharide diversity</li><li>Simpler glycan architectures</li></ul><h5>Animal-Derived Proteins (e.g., whey, egg white)</h5><ul><li>Greater structural complexity</li><li>Inclusion of diverse monosaccharides (e.g., sialic acids)</li><li>More elaborate branching patterns</li></ul>These differences have important implications for biological function and microbial interactions.<h4>Implications for Gut Microbiome Research</h4>N-glycans represent a potential class of prebiotic substrates that can influence gut microbiota composition and activity.Key findings suggest:<ul><li>Structural diversity of glycans affects microbial utilization patterns</li><li>More complex glycans may promote greater microbiome diversity</li><li>Specific glycan structures may selectively stimulate beneficial microbes</li></ul>This has led to growing interest in:<ul><li>Synbiotic strategies, combining microbes with preferred substrates</li><li>Tailored dietary interventions to enhance metabolic outputs, such as short-chain fatty acids</li></ul><h4>Methodological Considerations</h4>A critical insight from this work is the importance of understanding analytical trade-offs:<ul><li>MALDI-TOF MS provides broader detection of glycan structures</li><li>LC-MS approaches offer greater reproducibility</li></ul>No single technique is universally optimal; instead, method selection should be guided by the specific research question.<h4>Conclusion</h4>N-glycans in dietary proteins represent a complex and biologically significant class of biomolecules with implications spanning nutrition, microbiology, and disease research. Advances in analytical methodologies continue to improve our ability to characterize these structures, despite challenges related to low abundance and structural diversity.A deeper understanding of N-glycan composition and function may enable the development of targeted nutritional strategies and microbiome-based therapeutics, highlighting the growing importance of glycomics in modern life sciences.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

N‑Glycans, Whey Protein, and the Gut Microbiome: Mass Spec Insights with Matthew Bolino

<div><div><div>Our immune system is incredibly powerful: among other things, it can recognize and destroy cancer cells. But tumors can be just as effective at avoiding detection – they build “invisibility shields” to protect themselves from attack.</div></div><div>One breakthrough in cancer therapy has been immune checkpoint inhibitors (ICIs), drugs that reactivate immune T cells and help them fight tumors again. However, only about 20–50% of patients respond well to this treatment. Researchers are therefore seeking alternative therapeutic strategies. A small and well-known molecule called adenosine plays a key role in these efforts.When tumor cells are stressed or dying, they release ATP, which is normally a signal that something is wrong in the tissue. But in the tumor microenvironment, ATP gets rapidly broken down by two enzymes, CD39 and CD73. Released adenosine acts like a chemical “calm-down” signal, binds to immune cells (T cells, NK cells, and others), and tells them to slow down, reducing their ability to kill cancer cells. Targeting CD73 therefore represents a promising strategy for developing new cancer treatments.</div><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/UOCHB_Nove_latky_mohou_podporit_imunitni_system_v_boji_s_rakovinou_88c5e82cd5.jpeg" alt="IOCB Prague: Development of potent inhibitors to boost the immune system's ability to fight cancer" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_UOCHB_Nove_latky_mohou_podporit_imunitni_system_v_boji_s_rakovinou_88c5e82cd5.jpeg 245w," sizes="100vw" width="661" height="363">At IOCB Prague, interdisciplinary teams led by Jan Řezáč, Jan Konvalinka, and Michal Hocek used a newly developed high-throughput screening method to test over 5,000 compounds, identifying two ribonucleoside derivatives as promising CD73 inhibitors.The scientists then improved the compounds’ activity by carefully modifying the ribonucleoside scaffold with bulky (het)aryl groups. Further optimization improved the pharmacokinetic properties of these compounds, yielding inhibitors with low clearance, long half-life, high solubility, and strong selectivity over related enzymes such as CD39.In cellular experiments, the compounds reduced adenosine production in cancer cells, restored T cell activation, and showed no toxicity toward human fibroblasts. The most active compound showed a single-digit picomolar inhibition constant (Ki).These findings establish a strong foundation for further in vivo efficacy and combination studies, which will explore the therapeutic potential of this novel inhibitor class.<blockquote><h4>The Original article</h4><h4><a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acsptsci.5c00707">Potent Competitive Inhibitors of Ecto-5′-nucleotidase (CD73) based on 6-(Het)aryl-7-deazapurine Ribonucleoside 5′-O-Bisphosphonates</a></h4>Ugnė Šinkevičiu̅tė, Magdalena Šímová, Radek Staník, Lenka Poštová Slavětínská, Kristýna Blažková, Pavel Šácha, Martin Lepšík, Jan Řezáč, Jan Konvalinka, Tereza Ormsby, Michal Tichý, Michal HocekACS Pharmacol. Transl. Sci. 2026, 9, 1, 191–213<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acsptsci.5c00707">https://pubs.acs.org/doi/10.1021/acsptsci.5c00707</a><h6>licensed under <a target="_blank" rel="noopener noreferrer" href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a></h6></blockquote><h4>Abstract</h4>CD73 generates immunosuppressive adenosine in the tumor microenvironment and is a promising target for cancer immunotherapy. We have designed and systematically studied diverse 2-substituted 7-deazapurine ribonucleoside 5′-O-bisphosphonates bearing a variety of (het)aryl groups at position 6 and discovered their highly potent and selective CD73 inhibition activity. The most active compounds (with single-digit picomolar Ki) contained bicyclic (het)aryl groups at position 6 in combination with chlorine at position 2. Further optimization of pharmacokinetic properties identified inhibitors with low clearance, long half-life, high solubility, and excellent selectivity over CD39 and NTPDase3. They effectively suppressed adenosine formation in MDA-MB-231 cells, rescued CD8+ T cell activation, and were nontoxic to human fibroblasts. Overall, their profile compares favorably with AB680, a CD73 inhibitor currently in phase I/II clinical trials.</div>

Development of potent inhibitors to boost the immune system's ability to fight cancer

Article

Video

Scientists

Environment

Scientific article

Interview

Science and research

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. 

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Separation Science

Agilent Technologies

Technology Networks

Shimadzu Corporation

SCIEX

Waters Corporation

<h3>LC-MS/MS 201 webinar series</h3>
Advanced techniques for data acquisition and processing
<h4>Elevate your analytical expertise with advanced techniques and workflows</h4>
Sharpen your data acquisition and processing skills with our LC-MS/MS 201 webinar series. Based on our LC-MS/MS 101 webinar series, these sessions will go beyond the fundamentals of LC-MS/MS and introduce ways to advance your analytical methods and data processing workflows. Every other week, we will explore how to optimize SCIEX OS software with short, 30-minute expert-led presentations.
<h3>This webinar:</h3>
<h4>May 2, 2024</h4>
<h5>10:00 a.m. PT/ 1:00 p.m. ET - Automating data processing</h5>
<ul>
<li>Learn how to automate your data processing with custom flagging and rules for efficient data review in SCIEX OS software.</li>
</ul>
<h3>Other webinars from the series:</h3>
<h4>March 21, 2024</h4>
<h5>10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3705">Mastering chromatography</a></h5>
<ul>
<li>Discover how to optimize your chromatography for even the most challenging compounds while creating and building LC methods.</li>
</ul>
<h4>April 4, 2024</h4>
<h5>10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3706">It&#39;s a TRAP! Getting the most out of your QTRAP system</a></h5>
<ul>
<li>Learn when to utilize QTRAP functionality to create more selective and sensitive methods.</li>
</ul>
<h4>April 18, 2024</h4>
<h5>10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3707">Troubleshooting at the source</a></h5>
<ul>
<li>Acquire the knowledge needed to optimize source parameters and identify and resolve ionization-related problems.</li>
</ul>
<h4>May 16, 2024</h4>
<h5>10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3709">Excel strategies for mass spectrometry data analysis</a></h5>
<ul>
<li>Take an in-depth look at when and how to use Excel to increase your productivity.</li>
</ul>

Automating data processing in LC/MS

Learn how to automate your data processing with custom flagging and rules for efficient data review in SCIEX OS software.

<h3>MS School – Fundamentals of Mass Spectrometry Part 2</h3>
Mass spectrometry is a powerful analytical technique used to provide valuable information about the composition and structure of molecules. Understanding the fundamentals will empower you to make informed decisions about adding mass spectrometry to your laboratory analyses or maximizing the potential of your current MS systems.
In this educational webinar series, each session will cover a different aspect of mass spectrometry:
Part Two: Mass analyzers and detectors:
This session will look at the essential components of an MS system – the analyzer and the detector, focusing on quadrupole and time-of-flight systems. As well as showing how they operate, the session will outline the various types of experiments that can be run of each type of mass spectrometer.
<blockquote>
Presenter: Kieron Faherty, Ph.D. (Separations and Mass Spectrometry Field Marketing Manager, Waters Corporation)
</blockquote>
<blockquote>
Kieron Faherty is the Separations and Mass Spectrometry Field Marketing Manager for the Americas at Waters Corporation. He received his B.Sc. (Hons) in Chemistry from the University of Reading (Reading, Berkshire, UK) and his doctorate in Chemistry from the University of Massachusetts (Amherst, MA). He has held several field-based positions during his twenty-plus years at Waters, from Field Service Engineer on both quadrupole and Time-of-Flight MS systems to Principal Field Applications Specialist focused on biopharmaceutical applications.
</blockquote>

Waters Corporation: MS School – Fundamentals of Mass Spectrometry Series

Mass analyzers and detectors

This session will look at the essential components of an MS system – the analyzer and the detector, focusing on quadrupole and time-of-flight system.

<h3>MS School – Fundamentals of Mass Spectrometry Part 3</h3>
Mass spectrometry is a powerful analytical technique that provides valuable information about the composition and structure of molecules. Understanding the fundamentals will empower you to make informed decisions about adding mass spectrometry to your laboratory analyses or maximizing the potential of your current MS systems.
In this educational webinar series, each session will cover a different aspect of mass spectrometry:
Part Three: Coupling mass spectrometry to liquid chromatography:
This session will outline the factors which impact LC/MS methods, such as solvents and additives. The use of multiple detectors will also be discussed and the session will end with some “care and feeding” information for MS systems.
<blockquote>
Presenter: Kieron Faherty, Ph.D. (Separations and Mass Spectrometry Field Marketing Manager, Waters Corporation)
</blockquote>
<blockquote>
Kieron Faherty is the Separations and Mass Spectrometry Field Marketing Manager for the Americas at Waters Corporation. He received his B.Sc. (Hons) in Chemistry from the University of Reading (Reading, Berkshire, UK) and his doctorate in Chemistry from the University of Massachusetts (Amherst, MA). He has held several field-based positions during his twenty-plus years at Waters, from Field Service Engineer on both quadrupole and Time-of-Flight MS systems to Principal Field Applications Specialist focused on biopharmaceutical applications.
</blockquote>

Coupling mass spectrometry to liquid chromatography

This session will outline the factors which impact LC/MS methods, such as solvents and additives.

By attending this presentation, you will learn about:
<ul>
<li>The strategies for analyzing broad panels of pesticides with both LC/MS/MS and GC/MS/MS
</li>
<li>The approaches to address matrix interferences and consideration for instruments and methodologies
</li>
<li>Method validation requirements and accreditation criteria from the government perspective
</li>
</ul>
This presentation will review the laboratory perspective on the regulation and surveillance of approximately 270 pesticides and how this testing ties into federal government programs. Resulting methods used by the Ohio Department of Agriculture (ODA) Pesticide Residue laboratory show a lower quantitation limit at or below 10 parts per billion in complex matrices using a QuEChERS extraction paired with GC/MS/MS and LC/MS/MS. This work will summarize data found using these methods and compare goals, analysis requirements, and challenges between the USDA Agriculture Monitoring Service Pesticide Data Program and the U.S. EPA Region 5 with respect to pesticide use.
Additionally discussed will be strategies and challenges of using multiresidue methods on mass spectrometry platforms from the ODA including:
<ul>
<li>Workflow strategies
</li>
<li>Matrix interferences and cleanup
</li>
<li>Instrumental and methodological considerations, including compatibility of pesticides in these methods
</li>
<li>Method validation requirements and accreditation criteria
</li>
</ul>
<blockquote>
Presenter: Deidre E. Damon (Scientist and Mass Spectrometrist, Ohio Department of Agriculture’s Consumer Protection Laboratory)
</blockquote>
<blockquote>
Deidre Damon has been a scientist and mass spectrometrist for the Ohio Department of Agriculture’s Consumer Protection laboratory since 2019. She earned her PhD in analytical chemistry at the Ohio State University, focusing on alternative sampling and ionization sources for mass spectrometry. Since 2021, she has supervised the Pesticide Residue and Industrial Hemp laboratories where she oversees regulatory and surveillance testing of pesticides in environmental and food commodities on behalf of the U.S. EPA, USDA, and FDA for the state of Ohio.
</blockquote>

Separation Science - A Government Perspective on Pesticide Surveillance and Enforcement in Food and the Environment

A Government Perspective on Pesticide Surveillance and Enforcement in Food and the Environment

Learn about the strategies for analyzing broad panels of pesticides with both LC/MS/MS and GC/MS/MS

A Government Perspective on Pesticide Surveillance

Join us for an insightful webinar delving into the complexities surrounding nitrosamines in pharmaceutical products. Nitrosamines - known carcinogens, have emerged as a critical concern in the pharmaceutical industry, triggering stringent regulatory scrutiny. This webinar will explore the compendial standards, regulatory landscape, and analytical hurdles associated with detecting and mitigating nitrosamine contamination.
Gain invaluable insights from experts as we navigate the multifaceted challenges and discuss practical strategies for compliance and risk management.
Key Learnings:
<ul>
<li>Best practices for conducting risk assessment and testing for nitrosamine impurities
</li>
<li>How to assess the risk associated with Nitrosamines and developing control strategies
</li>
<li>Workflow for 17 Nitrosamines covering Sample Prep and LC-MS/MS method
</li>
<li>Control strategies aimed at addressing sensitivity, selectivity, and reproducibility issues with particular emphasis on sample preparation challenges
</li>
</ul>
<blockquote>
Presenter: Dr. Amanda Guiraldelli, Ph.D (Scientific Affairs Manager, United States Pharmacopeia)
</blockquote>
<blockquote>
Amanda Guiraldelli has been with USP since 2012 and holds the position of scientific affairs manager. She also serves as scientific liaison for the USP Measurement and Data Quality Expert Committee, where she works to develop and revise USP standards related to analytical procedure lifecycle/validation. Previously, Amanda worked as senior scientist at the USP reference standard laboratory for 8 years with characterization of compendial standards. She is visiting professor at the Institute of Chemistry at the University of Campinas (UNICAMP) in Brazil and is a frequent speaker and instructor on topics related to analytical procedure life cycle, AQbD and Chromatography.
</blockquote>
<blockquote>
Amanda is specialist in mass spectrometry, chromatography, omics and chemometrics and has more than 15 years of experience in pharmaceutical R&amp;D areas. Prior to joining USP, she was R&amp;D scientist in a Brazilian pharmaceutical industry and visiting scientist at TU Berlin in Germany and Leiden University in Netherlands (Center for Proteomics and Metabolomics) working on proteins characterization by LC-HRMS and procedure development using UHPLC-HRMS. Amanda is graduated in pharmacy biochemistry and holds a Ph.D. in analytical chemistry from the FCFRP - University of São Paulo (metabolomics by UHPLC-HRMS, GC-MS and 1H NMR and chemometrics).
</blockquote>
<blockquote>
Presenter: Mr. Naiffer Romero (MSc, MPH, United States Pharmacopeia)
</blockquote>
<blockquote>
Naiffer has more than 19+ years of pharmaceutical industry experience. In his 15 years with USP, he has served several roles: lead scientist in performance testing compendial reference standards development, Manager in charge of LATAM Compendial engagement and education with stakeholders and national regulatory bodies, and certified USP Education instructor.
</blockquote>
<blockquote>
Naiffer joined USP’s Scientific Affair performance cell in 2020, where he leads scientific outreach and technical engagement for LATAM &amp; US region on critical national health priority topics. His combined pharmaceutical expertise includes Analytical development, salt and polymorph selection, Development of dissolution methods, IVIVC modeling, and impurity analytical strategy. Naiffer is a recognized subject matter expert in Nitrosamines Impurities, and he also serves as a member of USP’s Nitrosamine workstream Committee and community manager to ‘Nitrosamine Exchange’, a knowledge community hosted by USP in All-things Nitrosamines Impurities.
</blockquote>
<blockquote>
Naiffer also liaises technical discussions on pharmacopeial collaboration, including the International Meeting of World Pharmacopeias (part of WHO), international compendial discussion groups, and several regional regulatory agencies’ nitrosamines working groups.
</blockquote>
<blockquote>
Presenter: Mr. Tobias Weimer (Produktspezialist LC &amp; LC/MSD, Agilent Technologies) 
</blockquote>
<blockquote>
Tobias hat in Marburg an der Philipps Universität Chemie studiert Seine Leidenschaft für die analytische Chemie und Chromatographie wurde bereits in der Oberschule geweckt und im Studium vertieft mit einer gezielten Ausrichtung auf analytische Trenntechniken. Über die Flüssigkeitschromatographie im Bereich LC Säulen führte Ihn sein Weg zu LC Systemen.
</blockquote>

Agilent: Unraveling Nitrosamines: Navigating Compendial, Regulatory, and Analytical Challenges

Unraveling Nitrosamines: Navigating Compendial, Regulatory, and Analytical Challenges

Webinar will explore the compendial standards, regulatory landscape, and analytical hurdles associated with detecting and mitigating nitrosamine contamination.

Unraveling Nitrosamines: Navigating Compendial, Regulatory

Human blood plasma contains thousands of distinct lipid species. These lipids can provide new insights into health and disease, with lipidomic profiling revealing new biomarkers for various conditions and being used to monitor the efficacy of treatments.
This webinar explores a new workflow for lipidomics using dia-PASEF – a mass spectrometry approach that allows for faster, more comprehensive analysis. Our expert speaker will show how this method increases lipid library coverage by 60% and allows you to capture complete lipid data in a single run. They will also unveil the optimal approach for high-throughput lipid analysis in human plasma, helping you to enhance your lipidomics research. 
Attend this webinar to:
<ul>
<li>Increase your lipid library coverage with dia-PASEF</li>
<li>Hear how to gain complete lipid data in a single run</li>
<li>Discover an optimized analysis scheme for high-throughput lipidomics</li>
</ul>
<blockquote>
Presenter: Dr. Hannes Röst (Assistant Professor and Canada Research Chair in Mass Spectrometry-Based Personalized Medicine at University of Toronto)
</blockquote>
<blockquote>
I am a bioinformatics researcher interested in high-throughput technologies that allow us to study the molecular phenotype of a biological system comprehensively. I have worked on theoretical questions in targeted proteomics, contributed to the development of SWATH-MS and wrote the first software capable of targeted analysis of SWATH-MS data in high throughput. I studied at ETH Zurich, Switzerland, worked with Ruedi Aebersold during my PhD and I am now working with Mike Snyder at Stanford University to apply mass spectrometry in a personalized medicine context.
</blockquote>

Technology Networks: Next-Generation Plasma Lipidomics: Quantification With dia-PASEF

Next-Generation Plasma Lipidomics: Quantification With dia-PASEF

New workflow for lipidomics using dia-PASEF – a mass spectrometry approach that allows for faster, more comprehensive analysis.

Plasma Lipidomics: Quantification With dia-PASEF

<h4>LC-MS/MS fundamentals webinar series 2.0</h4>
Advanced techniques for data acquisition and processing
Elevate your analytical expertise with advanced techniques and workflows
Sharpen your data acquisition and processing skills with our LC-MS/MS 2.0 webinar series. Based on our LC-MS/MS 1.0 webinar series, these sessions will go beyond the fundamentals of LC-MS/MS and introduce ways to advance your analytical methods and data processing workflows.
Every other week, we will explore how to optimize SCIEX OS software with short, 30-minute expert-led presentations.
<h4>This webinar:</h4>
May 7, 2024 11:00 a.m. - 11:30 a.m. CET - Beyond the fundamentals
<h4>Other webinars from the series:</h4>
May 21, 2024 11:00 a.m. - 11:30 a.m. CET - <a href="https://lcms.labrulez.com/webinar/3852">Advanced MS/MS method building</a>
Gain insight into advanced features for maximizing sensitivity in your mass spectrometry analyses.
June 4, 2024 11:00 a.m. - 11:30 a.m. CET - <a href="https://lcms.labrulez.com/webinar/3853">Mastering chromatography</a>
Discover how to optimize your chromatography for even the most challenging compounds while creating and building LC methods.
June 18, 2024 11:00 a.m. - 11:30 a.m. CET - <a href="https://lcms.labrulez.com/webinar/3854">It&#39;s a TRAP! Getting the most out of your QTRAP system</a>
Learn when to utilize QTRAP functionality to create more selective and sensitive methods.
July 2, 2024 11:00 a.m. - 11:30 a.m. CET- <a href="https://lcms.labrulez.com/webinar/3855">Troubleshooting at the source</a>
Acquire the knowledge needed to optimize source parameters and identify and resolve ionization-related problems.
July 16, 2024 11:00 a.m. - 11:30 a.m. CET - <a href="https://lcms.labrulez.com/webinar/3856">Automating data processing</a>
Learn how to automate your data processing with custom flagging and rules for efficient data review in SCIEX OS software.
July 30, 2024 11:00 a.m. - 11:30 a.m. CET - <a href="https://lcms.labrulez.com/webinar/3857">Excel strategies for mass spectrometry data analysis</a>
Take an in-depth look at when and how to use Excel to increase your productivity.

SCIEX: LC-MS/MS fundamentals webinar series 2.0

Beyond the fundamentals

Sharpen your data acquisition and processing skills with our LC-MS/MS 2.0 webinar series.

Beyond the LC-MS/MS fundamentals

<ul>
<li>Gain insights into current food legislation relating to PFAS
</li>
<li>Learn about targeted and untargeted approaches for PFAS analysis using LC-MS/MS
</li>
<li>Uncover the capabilities of the LCMS PFAS in eggs analysis with online SPE clean-up
</li>
<li>Find out about the benefits of automated and &quot;ready-to-use&quot; methods
</li>
</ul>
<blockquote>
Presenter: Jonathan McGeeha (Food Safety Market Specialist, Shimadzu)
</blockquote>

PFAS in Food – A not so “eggs-cellent” discovery! Analytical approaches for PFAS in food

Join the webinar to learn more about analytical approaches into analysing PFAS in food.

Analytical approaches for PFAS in food

<h3>PFAS and us: The science</h3>
Driving change for a healthier world
Webinar series
<h4>Enrich your understanding of PFAS chemicals and their impact</h4>
Stay on the leading edge of all things PFAS with this enlightening monthly webinar series on testing workflows and cutting-edge technology that will demystify these “forever chemicals”.
Each month, in these 30-minute sessions, industry thought leaders unite to share the current state of PFAS testing and the far-reaching impact that PFAS have on human health and the environment. Build on your current knowledge of testing methodologies and research techniques that will help you develop your own innovative strategies for precise identification and quantitation. Make a lasting impact and join us for these conversations.
<h4>This Webinar:</h4>
May 8, 2024 10:00 a.m. PT/ 1:00 p.m. ET - Rapid PFAS testing with no compromises: direct-inject analysis
<blockquote>
Presenter: Jamie Fox (PFAS Technical Program Manager, Enthalpy Analytical)
</blockquote>
<h4>Other Webinars from the Series:</h4>
April 10, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3865">Examining the exogenous: PFAS and beyond</a>
<blockquote>
Presenter: Andrew Patterson (Vice President, Innovation and Development, Eurofins Environmental Testing America)
</blockquote>
June 12, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3867">Assessment of advanced analytical instruments to reach required limits of quantitation for PFAS in foods</a>
<blockquote>
Presenter: Susan Genualdi, PhD (Research Chemist, FDA, Center for Food Safety and Applied Nutrition, Office of Regulatory Science)
</blockquote>
July 17, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3868">Detecting and identifying known and novel per/polyfluoroalkyl substances (PFAS) in a marine apex predator</a>
<blockquote>
Presenter: Carrie McDonough (Assistant Professor, Chemistry, Carnegie Mellon University)
</blockquote>
August 14, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3869">Whole blood microsampling methods for PFAS exposure biomonitoring</a>
<blockquote>
Presenter: Andrew J. Morris, PhD (Professor, University of Arkansas for Medical Sciences, Research Career Scientist, Central Arkansas Veterans Affairs Healthcare System)
</blockquote>
September 11, 2024 10:00 a.m. PT/ 1:00 p.m. ET - <a href="https://lcms.labrulez.com/webinar/3870">Analysis of ultra short-chain PFCAs to better understand environmental sources and fate</a>
<blockquote>
Presenter: Cora J. Young (Associate Professor, Department of Chemistry, York University)
</blockquote>

Rapid PFAS testing with no compromises: direct-inject analysis

Stay on the leading edge of all things PFAS with this enlightening monthly webinar series.

Rapid PFAS testing: direct-inject analysis

<h5>By attending this presentation, you will learn:</h5>
<ul>
<li>Peptide analysis method development via the presentation of experiment results</li>
<li>An understanding of the Biotage sample preparation workflow and the benefits of automation</li>
</ul>
<h5>Event Overview</h5>
An overview of sample preparation approaches for the analysis of World Anti-Doping Agency (WADA) prohibited peptides from urine samples on LC-HRMS (Liquid Chromatography-High Resolution Mass Spectrometry).
The webinar will discuss sample preparation method development approaches undertaken to extract a panel of peptides using the full Biotage workflow. We will address the encountered challenges during development and share insights into optimizing recoveries and ensuring reproducibility for a range of analytes. We will also highlight the benefits of automating these methods to ensure reproducible analysis and free up laboratory analysts&#39; time for other important laboratory tasks.
The webinar is aimed at human and animal sport doping laboratories interested in preparing biofluids for peptide analysis. Attendees will benefit from a deepened understanding of how to achieve clean samples with reproducible results, thereby empowering laboratories to maintain the highest standards of analytical excellence in the field of anti-doping testing.
<h5>What you need to know:</h5>
<ul>
<li>Broadcast #1: 6 June - 10 am BST (London) / 11 am CEST (Paris/Berlin) / 2:30 pm IST (New Delhi) / 5 pm SGT (Singapore)
</li>
<li>Broadcast #2: 6 June - 10 am PDT (Los Angeles) / 12 pm CDT (Chicago) / 1 pm EDT (New York)
</li>
</ul>
<blockquote>
Presenter: Thomas Smith (EU Applications Team Leader, Biotage)
</blockquote>
<blockquote>
Thomas has been with Biotage since July 2022 and is supporting customers to improve and streamline their sample preparation approaches and helping them automate their manual, labor-intensive tasks in the laboratory. Before this role, Thomas worked in a toxicology lab analyzing hair for drugs of abuse and alcohol markers. His main role here was to automate a method to increase reproducibility and turnaround time to meet the growing sample numbers.
</blockquote>

Separation Science: Novel Method Development Approaches for Peptide Analysis in Doping

Novel Method Development Approaches for Peptide Analysis in Doping

The webinar is aimed at human and animal sport doping laboratories interested in preparing biofluids for peptide analysis.

LCMS webinars focusing on LC/MS - page 61